July 11, 2008
Kinetic Concepts, Inc. Announces Date of Its Second Quarter 2008 Earnings Release and Conference Call
Kinetic Concepts, Inc. (NYSE:KCI), today announced that it will report its second quarter 2008 financial results on Thursday, July 24, 2008, at 6:30 a.m. EDT. The Company's senior management team will also host an investor conference call to discuss second quarter results and current business trends on Thursday, July 24, 2008, at 8:30 a.m. EDT.
To access the conference call, domestic participants may dial 888-313-5249 at least 10 minutes before the call is scheduled to begin. International participants may dial +706-679-5386.
A live web cast of the presentation will also be available at the Company's investor relations website at http://www.kci1.com/investor/index.asp . The web cast will be archived on the investor relations website for a period of twelve months.
Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing - and the lives - of patients around the world.
KCI's three primary businesses include:
Advanced Wound Care - Includes KCI's proprietary Vacuum Assisted Closure(R), or V.A.C.(R) Therapy System, which has been clinically demonstrated to promote wound healing through unique mechanisms of action while reducing the overall cost of treating patients with complex wounds.
Tissue Regeneration - Represented by KCI's LifeCell business and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.
Therapeutic Support Systems - Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, to reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size.
The company employs 7,000 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit www.KCI1.com.